Difference between revisions of "Schott AF, et al. Clin. Cancer Res. (2013) cited as Ref 579 in DOI: 10.1038/s41392-020-0110-5 (Q9842)"
Jump to navigation
Jump to search
(Created claim: title (P93): Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 1512-1524, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 1512-1524 | ||
| Property / Page(s): 1512-1524 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:45, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Schott AF, et al. Clin. Cancer Res. (2013) cited as Ref 579 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Schott AF
0 references
2013
0 references
Clin. Cancer Res.
0 references
19
0 references
Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors (English)
0 references
1512-1524
0 references
